H2020: EuroGCT: European consortium for communicating gene- and cell-based therapy information.

Project Details

Description

EuroGCT has two major objectives:
• To provide patients, people affected by conditions, healthcare professionals and citizens with accurate scientific, legal, ethical and societal information and with engagement opportunities, and thus to support better informed decisionmaking related to cell and gene-based therapies.
• To facilitate better decision-making at key points in development of new therapies and thus enable improved product development, by providing the research community and regulatory

Funding Acknowledgement(s)

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 965241

-
AcronymEUAR58
StatusActive
Effective start/end date1/02/2131/01/26

Funding

  • European Commission

Keywords

  • information
  • communication
  • engagement
  • cell therapy
  • gene therapy
  • genome editing
  • stem cells
  • research
  • clinical trials
  • regulation
  • ethics
  • patients
  • industry
  • manufacturing
  • IPR

Flemish discipline codes

  • Cellular therapy